A clinical study of Bhudhatryadi Ghana vati for the treatment in patients of Type-2 Diabetes Mellitus

Clinical evaluation of Reversibility of Prameha with Bhudhatryadi Ghanavati and pathya ahara WSR to type-2 Diabetes Mellitus - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/066438

Enrollment

120

Registered

2024-04-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having signs and symptoms of Prameha (Type 2 Diabetes) 2. Patients fulfilling subjective and objective criteria 3. Patients irrespective of sex, caste and religion 4. Patients who are on oral hypoglycemic drugs but still having Hyperglycemia

Exclusion criteria

Exclusion criteria: 1.Patients less than 20 years more than 70 years of age 2.Patients of Diabetes mellitus receiving insulin 3.Patients having chronic complications of Diabetes mellitus 4.Other chronic debilitating disease like STD etc. 5.Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Subjective Parameter- Grading will be done with signs and symptoms of Prameha (type 2 Diabetes) RFT FBS PPBS HBA1CTimepoint: After one month intervention of Bhudhatryadi Ghanavati orally and 15 days after stopping of medicine	—

Secondary

Measure	Time frame
Subjective Parameter- Grading will be done with signs & symptoms of Prameha (type 2 Diabetes) RFT FBS PPBS HBA1CTimepoint: After 45 days from the start of the medicine	—

Countries

India

Contacts

Public ContactVaidya Rakesh Sharma

Guru Ravidas Ayurved University Hoshiarpur

vaidyaras03@gmail.com9814779242

Outcome results